No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX) and Boundless Bio Inc. (BOLD)
Express News | Boundless Bio : Sales Agreement Prospectus Covering Offering of up to $14.5 Million of Common Stock
Express News | Boundless Bio Inc Files for Mixed Shelf of up to $400 Mln – SEC Filing
Guggenheim Sticks to Its Hold Rating for Boundless Bio Inc. (BOLD)
Boundless Bio | 10-K: FY2024 Annual Report